Natrix Separations to Launch NatriFlo™ HD-Q
Membrane Adsorbers at BPI Conference and
Exhibition in Boston
Burlington, Ontario, September 13, 2013 — Natrix Separations, Inc., a maker of innovative single-use chromatography products for the biopharmaceutical industry, announced that it will launch its NatriFlo® HD-Q Flow-Through Membrane Adsorber product family at the BioProcess International Conference and Exhibition in Boston, September 17-19. Natrix will also unveil its new commercial partnership with JSR Life Sciences at the BPI event (Booth 924).
NatriFlo HD-Q is the first of several product lines to employ Natrix HD Membrane technology, which features a revolutionary three-dimensional macroporous hydrogel structure that provides a High Density of binding sites and rapid mass transfer. Natrix HD Membranes deliver binding capacity that exceeds resin-based columns with fast flow-rates typical of membrane adsorbers. This combination of performance and speed enables NatriFlo HD-Q membrane adsorbers to achieve:
- Best-in-class Viral Clearance, HCP and DNA removal, even with the most challenging feedstreams....with plenty of capacity to spare
- Salt and pH tolerance in an industry-standard strong anion exchange (Q) chemistry (even in phosphate buffer systems)
- Simple, low cost polish operations in a single-use format
The NatriFlo family offers scalable polishing from R&D to cGMP manufacturing.
“We have spent the past 18 months working with leading biopharmaceutical partners to evaluate and prove the performance of NatriFlo products for polish applications. The data our partners have produced unequivocally demonstrate that NatriFlo delivers a new level of low-cost, highly flexible productivity in their purification operations,” said John Chickosky, Natrix Separations President & CEO.
Chickosky added, “We are also thrilled to introduce our commercial partnership with JSR Life Sciences, who will be our global distributor. JSR has built a sterling reputation over the past 50 years as a premier specialty chemical maker, and has established itself in the biopharmaceutical industry in recent years with its impressive development of Amsphere™ Protein A resin. JSR’s global presence, operational excellence and organizational scale make them an ideal partner for launching our exciting new products to bioprocess customers around the world.”